A C.D.C. panel will meet today on the Johnson & Johnson vaccine pause.
Health
By BY CARL ZIMMER from NYT Health https://ift.tt/32DyC1F
via IFTTT internal-essential, Blood Clots, Vaccination and Immunization, Coronavirus (2019-nCoV), Labeling and Labels (Product) The U.S. government is likely to end the pause if the panel says the vaccine’s benefits outweigh the potential risk.

By BY CARL ZIMMER from NYT Health https://ift.tt/32DyC1F
via IFTTT internal-essential, Blood Clots, Vaccination and Immunization, Coronavirus (2019-nCoV), Labeling and Labels (Product) The U.S. government is likely to end the pause if the panel says the vaccine’s benefits outweigh the potential risk.
Comments
Post a Comment